Tag: Astrazeneca Monoclonal Antibody

AstraZeneca Monoclonal Antibody Therapy Fails To Prevent COVID-19 Symptoms
AstraZeneca Monoclonal Antibody Therapy Fails To Prevent COVID-19 Symptoms

The Covid-19 antibody therapy -- AZD7442 -- was only 33 per cent effective in reducing the risk of symptoms, when compared to a placebo, according to the results of a Phase 3 trial.